Ion Beam Applications SA
Frederic Jodocy began their work experience in 1993 at Solvay, starting as a Sales and Logistics Assistant and working their way up to become the Export Sales Manager and then the Supply Chain Manager. Frederic joined IBA in 2010 as an Area Sales Manager and later became the Vice President Sales EMEA. Currently, Frederic holds the position of Vice President of Global Sales at IBA.
Frederic Jodocy attended Athénée Emile Bockstael from 1982 to 1988, where they studied Sciences. Frederic then went on to study at the Université libre de Bruxelles from 1988 to 1990. From 1990 to 1993, they attended the Institut Lucien Cooremans, focusing on Transport and Logistics.
This person is not in any teams
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.